32
Some 365 generic drugs have had their European Union marketing authorisations suspended after an investigation raised concerns about the reliability of the company that tested them.1
The European Medicines Agency’s human medicines committee reviewed 400 generic medicines that have been tested by Synapse Labs, a contract research organisation (CRO) located in Pune, India.2 Of these, just 35 …
